PET/SPECT imaging: From carotid vulnerability to brain viability

European Journal of Radiology

Volumn 74, Issue 1, 2010, Pages 104-109

  Meerwaldt, Robbert ^a   Slart, Riemer H J A ^b   van Dam, Gooitzen M ^b   Luijckx, Gert Jan ^b   Tio, René A ^b   Zeebregts, Clark J ^b  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Brain viability; Carotid plaque vulnerability; Ischemic stroke; Positron emission tomography; Single photon emission computed tomography

Indexed keywords

CAROTID PLAQUES; CLINICAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TOOLS; FUNCTIONAL IMAGING; HIGH-RISK PATIENTS; ISCHEMIC STROKE; ISCHEMIC STROKES; KEY ISSUES; LITERATURE SEARCH; OBSERVATIONAL STUDY; VULNERABLE PLAQUES;

PARTICLE BEAMS; PHOTONS; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RISK ASSESSMENT;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ATHEROMA; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR ACCIDENT; HIGH RISK PATIENT; HUMAN; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BIBLIOGRAPHY OF MEDICINE; BRAIN ISCHEMIA; CAROTID STENOSIS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77950081023     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.01.034     Document Type: Review

References (64)

1. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113 (2006) e873-e923
2. Meyers P.M., Schumacher H.C., Higashida R.T., Leary M.C., and Caplan L.R. Use of stents to treat extracranial cerebrovascular disease. Annu Rev Med 57 (2006) 437-454
3. Jander S., Sitzer M., Schumann R., et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 29 (1998) 1625-1630
4. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
5. Anonymous. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial Collaborative Group). Lancet 349 (1997) 1641-1649
6. Anonymous. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 349 (1997) 1569-1581
7. Astrup J., Siesjo B.K., and Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 12 (1981) 723-725
8. Bengel F.M. Atherosclerosis imaging on the molecular level. J Nucl Cardiol 13 (2006) 111-118
9. Anonymous. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998) 1379-1387
10. Anonymous. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 (1991) 445-453
11. Anonymous. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273 (1995) 1421-1428
12. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363 (2004) 1491-1502
13. Geng Y.J., and Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 22 (2002) 1370-1380
14. Glass C.K., and Witztum JL. Atherosclerosis. The road ahead. Cell 104 (2001) 503-516
15. Sukhova G.K., Schonbeck U., Rabkin E., et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99 (1999) 2503-2509
16. Schwartz S.M., Virmani R., and Rosenfeld M.E. The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2 (2000) 422-429
17. Libby P., Geng Y.J., Sukhova G.K., Simon D.I., and Lee R.T. Molecular determinants of atherosclerotic plaque vulnerability. Ann NY Acad Sci 811 (1997) 134-142
18. Aikawa M., and Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 13 (2004) 125-138
19. Libby P., Geng Y.J., Aikawa M., et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7 (1996) 330-335
20. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., and Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26 (2001) 314-319
21. 18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 126 (2000) 549-559
22. 18F-choline images murine atherosclerotic plaques ex vivo. Arterioscler Thromb Vasc Biol 26 (2006) 584-589
23. Ohtsuki K., Hayase M., Akashi K., Kopiwoda S., and Strauss H.W. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 104 (2001) 203-208
24. Lees A.M., and Lees R.S. 99mTechnetium-labeled low density lipoprotein: receptor recognition and intracellular sequestration of radiolabel. J Lipid Res 32 (1991) 1-8
25. Schafers M., Riemann B., Kopka K., et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 109 (2004) 2554-2559
26. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imag 33 (2006) 117-126
27. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., and Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
28. Boersma H.H., Kietselaer B.L., Stolk L.M., et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46 (2005) 2035-2050
29. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
30. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36 (2005) 2642-2647
31. Arauz A., Hoyos L., Zenteno M., Mendoza R., and Alexanderson E. Carotid plaque inflammation detected by (18)F-fluorodeoxyglucose-positron emission tomography pilot study. Clin Neurol Neurosurg 109 (2007) 409-412
32. 18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49 (2007) 1533-1539
33. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 (2006) 1825-1831
34. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 49 (2008) 871-878
35. 18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries. Reproducibility, partial volume correction, and correlation between methods. Stroke; October 16, 2008 [Epub ahead of print].
36. 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes. Eur J Nucl Med Mol Imag 33 (2006) 474-482
37. 99mTc-labeled low density lipoproteins. Arteriosclerosis 8 (1988) 461-470
38. Iuliano L., Signore A., Vallabajosula S., et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis 126 (1996) 131-141
39. Rudd J.H., Myers K.S., Bansilal S., et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 50 (2007) 892-896
40. Baron J.C. Positron tomography in cerebral ischemia. A review. Neuroradiology 27 (1985) 509-516
41. Wise R.J. Positron emission tomography in the study of cerebral ischaemia. J Cereb Blood Flow Metab 2 Suppl. 1 (1982) S87-S89
42. Powers W.J., Grubb Jr. R.L., Darriet D., and Raichle M.E. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 5 (1985) 600-608
43. Heiss W.D., and Podreka I. Role of PET and SPECT in the assessment of ischemic cerebrovascular disease. Cerebrovasc Brain Metab Rev 5 (1993) 235-263
44. Yamauchi H., Fukuyama H., Fujimoto N., Nabatame H., and Kimura J. Significance of low perfusion with increased oxygen extraction fraction in a case of internal carotid artery stenosis. Stroke 23 (1992) 431-432
45. Heiss W.D., Grond M., Thiel A., et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 18 (1998) 1298-1307
46. 2 reactivity measured by the intravenous 133 xenon injection technique. J Neurol Neurosurg Psychiatry 51 (1988) 1045-1050
47. 18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 30 (2003) 317-326
48. 18F-fluoromisonidazole and positron emission tomography: a pilot study. J Cereb Blood Flow Metab 27 (2007) 679-689
49. 18F]FAZA: reaction parameters and automation. Appl Radiat Isotopes 62 (2005) 897-901
50. Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115 (2007) e478-e534
51. Kidwell C.S., and Hsia A.W. Imaging of the brain and cerebral vasculature in patients with suspected stroke: advantages and disadvantages of CT and MRI. Curr Neurol Neurosci Rep 6 (2006) 9-16
52. Kidwell C.S., and Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke 34 (2003) 2995-2998
53. Heiss W.D., Graf R., and Wienhard K. Relevance of experimental ischemia in cats for stroke management: a comparative reevaluation. Cerebrovasc Dis 11 (2001) 73-81
54. Mahagne M.H., Darcourt J., Migneco O., et al. Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery. Cerebrovasc Dis 10 (2000) 364-373
55. 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT. J Nucl Med 42 (2001) 543-547
56. 99mTc-ECD SPECT in acute and subacute ischemic stroke: comparison with MR images including diffusion and perfusion weighted images. Yonsei Med J 43 (2002) 211-222
57. Yamamoto K.K., Miyata T., Momose T., et al. Reduced vascular reserve measured by stressed single photon emission computed tomography carries a high risk for stroke in patients with carotid stenosis. Int Angiol 25 (2006) 385-388
58. Aso K., Ogasawara K., Sasaki M., et al. Preoperative cerebrovascular reactivity to acetazolamide measured by brain perfusion SPECT predicts development of cerebral ischemic lesions caused by microemboli during carotid endarterectomy. Eur J Nucl Med Mol Imag (2008)
59. Murakami M., Fujioka S., Hirata Y., and Kuratsu J. Low-dose of statin treatment improves cerebrovascular reactivity in patients with ischemic stroke: single photon emission computed tomography analysis. J Stroke Cerebrovasc Dis 17 (2008) 16-22
60. Donnan G.A., and Davis S.M. Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol 1 (2002) 417-425
61. Ringer T.M., Neumann-Haefelin T., Sobel R.A., Moseley M.E., and Yenari M.A. Reversal of early diffusion-weighted magnetic resonance imaging abnormalities does not necessarily reflect tissue salvage in experimental cerebral ischemia. Stroke 32 (2001) 2362-2369
62. Guadagno J.V., Warburton E.A., Jones P.S., et al. How affected is oxygen metabolism in DWI lesions? A combined acute stroke PET-MR study. Neurology 67 (2006) 824-829
63. Grandin C.B., Duprez T.P., Smith A.M., et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 223 (2002) 361-370
64. Heiss W.D., and Sobesky J. Comparison of PET and DW/PW-MRI in acute ischemic stroke. Keio J Med 57 (2008) 125-131